Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Organon, Samsung Bioepis launch HUMIRA biosimilar HADLIMA in US Organon & Co. and Samsung Bioepis revealed that HADLIMA (adalimumab-bwwd), a biosimilar referencing Humira (adalimumab), is now accessible… byPallavi MadhirajuJuly 1, 2023